3SixtyPublicAffairs

How Can We Better Protect Older Canadians – A Booster Shot for Canada’s Vaccine Policies Join Ronald Grossman @uoftmedicine; @ltamblynwatts @CanAgeSeniors; Jennifer Chan @MerckCanada; Moderator Bill Dempster, @3SixtyPA for a #LeadershipDiscusson on Feb 6. longwoods.com/events/leaders…

The federal health committee is wrapping up its review of Bill-C64, An act respecting pharmacare. Want to know what happens next? 3Sixty’s new infographic explains the entire process including next steps after the bill passes.

Spotted 👀 3Sixty’s Fred Horne discusses patient-centric healthcare @GISociety’s #InsideAffair

@billdempster de 3Sixty partage ses réflexions sur ce qui promet d'être une année très chargée pour le secteur de la santé et des sciences de la vie à la Journée du Québec @CAHR_ACRSS

3Sixty's @billdempster and Gerry Jeffcott are PharmaFocused at IQVIA's Industry Briefing in Montreal😎

3Sixty is thrilled to announce two new additions to our growing team. Please join us in welcoming Chris Gray and Doug Nanton to the 3Sixty family 👏👏 linkedin.com/feed/update/ur…

Your favourite duo is back for some more “eye spy with my little eye” on the way to next week’s IQVIA’s Industry Briefings in Toronto (Apr 16) and Montreal (Apr 17)! See you there!

Canadian Pathway to Rare Disease Drug Access: Sherry O’Quinn, @MorseConsult; Lindy Forte, @EVERSANAcompany ; Alexandra Chambers, @Bayer ; Joan Paulin, @PHACanad Bonnie Kam, @JanssenCanada, Rute Fernandes, @TakedaPharma moderated by Bill @3SixtyPA

Thank you 👏Impacts on Rare Disease Drugs Panel Quebec Rules: Implications for Rare Sylvie Bouchard, @INESSS_Qc at the Podium @billdempster moderating @3SixtyPA, PMPRB Regulatory Changes @waynedcritchley , @GPAinsights Emerging Therapies Bob McLay, @SobiNAmerica

👀Spotted: 3Sixty's Gerry Jeffcott at @CAHR_ACRSS Western Day.

A huge thank you to all our sponsors for their continued support! @3SixtyPA @AstraZeneca @biogen @innovativemeds @Innomar_AB @AbbottNews @WestPAR_Inc @CSL @MorseConsult @VertexPharma @Roche @bauschhealth @moderna_tx @GlobalPublicAff @Novartis

Happy holidays from the 3Sixty team! #XmasPartyShenanigans #NoFilter @billdempster

All smiles at @CAHR_ACRSS National Day 😎

Fantastic afternoon of collaborative efforts! 🤝 Huge shoutout to the amazing facilitators, @billdempster @3SixtyPA, for steering the ship. 🚀 Grateful for the teamwork at #Canada4Rare during #CORDFallConf in #Calgary! 🇨🇦

3Sixty's @billdempster doing his thing at CORD's (@raredisorders) Fall #RareDisease Conference! Inspiring community. Amazing discussions. 👏 #Canada4Rare

Bill Dempster from @3sixtyPublicAffairs provides insights on the federal rare disease drug strategy & emerging provincial strategies: what they mean for pharmacies and how to shape implementation #NPSummit

🚨Registration now open for Module#3 of a 3-part @CAMO_ACOM series #Cancer #drugs #funding in 🇨🇦 🗓️Nov 30 #Virtual 7pm EST Register➡️camo-acom.ca/event-5498939 @GillSharlene @3SixtyPA @pwheatleyprice @camoprez

The @pharmacy_CAN Specialty Pharmacy Summit is almost here! Day 2 Session Spotlights: Join Bill Dempster for "Implementing the Drugs for Rare Diseases Strategy" and Andrew Bakhit for "Technology Trends for Delivering Specialty Services" #NPSummit

Don’t miss this opportunity to be part of an informative dialogue where our speakers, and panelists will address the #evolving #pharmaceutical #policy and how the market adapts to a reset. The conference will be moderated by Bill Dempster, CEO, @3SixtyPA

🚨Registration now open for Module#2 of a 3-part @CAMO_ACOM series on #Cancer #drugs #funding in 🇨🇦 🗓️Nov 15 #Virtual 7pmEST Register➡️camo-acom.ca/event-5472021 @GillSharlene @camoprez @3SixtyPA